J Clin Oncol. 2019 Dec 11:JCO1900931. doi: 10.1200/JCO.19.00931. [Epub ahead of print]
PROTAC Targeting LZK Shows Promise for Treating HNSCC – NCI Center for Cancer Research / Amy L Funk, Anna A Marusiak, cancer, Carolyn C Woodroofe,…
A variety of factors influence a patient’s clinical outcome, including intrinsic characteristics of the patient, disease, or medical condition, and the effects of any treatments…
Vivek Subbiah: Sharing the Key Advances in Oncology and Exciting Publications from ASCO25 / Annals of Oncology, ASCO25, C. Ola Landgren, cancer, CAR T-cell
The public should adopt the “wet-bulb globe temperature.”
The conspiracy theories about Joe Biden’s diagnosis perpetuate harmful myths.
First-line therapy for advanced non–small-cell lung cancer (NSCLC) that lacks targetable mutations is platinum-based chemotherapy. Among patients with a tumor proportion score for programmed death…
ACS CAN is the nation’s leading cancer advocacy organization that is working every day to make cancer issues a national priority.
Thrombotic microangiopathy (TMA) is a clinical syndrome characterized by endothelial injury and thrombotic occlusion of the microvasculature, leading to end-organ damage. This systemic disorder can affect…
NCBI’s Gene Expression Omnibus (GEO) is a public archive and resource for gene expression data.
Interleukin-10 (IL-10) presents a dual role in systemic lupus erythematosus (SLE), illustrating pro-inflammatory and anti-inflammatory effects. This study addressed the possible associations between serum IL-10…
